According to the North American Industry Classification System, Thermo Fisher Scientific sits…

According to the North American Industry Classification System, Thermo Fisher Scientific sits within the medical laboratories industry. The industry aims to provide the healthcare sector with the resources it needs to better diagnose and analyze the cause, severity, and hopeful remediation of a patient’s illnesses. This industry is responsible for doing research about cutting edge biomedical technologies and helping create drugs, vaccines, and diagnostic capabilities. They also build equipment like chromatography instruments, DNA sequencers, and test kits. The industry is also responsible for building software that help make many aspects of healthcare more efficient and cost effective.

Thermo Fisher Scientific is dominant in the industry. They trump to their main competitors with revenues of $20.92 billion stemming from several different markets. Competitors seem to be more specifically focused. Agilent Technologies, Danaher, and Bio-Rad are three publicly traded competitors that seem to have a smaller breadth of services.

Agilent technologies has revenues of $4.5 billion, with 14,800 employees. They are focused on public research, development, and manufacturing. Danaher technologies is Thermo Fisher’s second biggest rival and they design, manufacture, and market professional, medical, and commercial products and services. They employ 71,000 people and generate revenues of $18.33 billion. Bio-Rad is much smaller, with 8,150 employees. They have revenues of $2.3 billion and they manufacture and distribute life science research and clinical diagnostics products.

Document Preview:

Industry Overview According to the North American Industry Classification System, Thermo Fisher Scientific sits within the medical laboratories industry. The industry aims to provide the healthcare sector with the resources it needs to better diagnose and analyze the cause, severity, and hopeful remediation of a patient’s illnesses. This industry is responsible for doing research about cutting edge biomedical technologies and helping create drugs, vaccines, and diagnostic capabilities. They also build equipment like chromatography instruments, DNA sequencers, and test kits. The industry is also responsible for building software that help make many aspects of healthcare more efficient and cost effective. Thermo Fisher Scientific is dominant in the industry. They trump to their main competitors with revenues of $20.92 billion stemming from several different markets. Competitors seem to be more specifically focused. Agilent Technologies, Danaher, and Bio-Rad are three publicly traded competitors that seem to have a smaller breadth of services. Agilent technologies has revenues of $4.5 billion, with 14,800 employees. They are focused on public research, development, and manufacturing. Danaher technologies is Thermo Fisher’s second biggest rival and they design, manufacture, and market professional, medical, and commercial products and services. They employ 71,000 people and generate revenues of $18.33 billion. Bio-Rad is much smaller, with 8,150 employees. They have revenues of $2.3 billion and they manufacture and distribute life science research and clinical diagnostics products. Thermo Fisher Scientific operates in several segments under different sub-brands. The four main segments that the company competes in are life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services. The life sciences solutions segment includes medical and biological research. Thermo Fisher serves this market by creating instruments and…

Attachments:

"Is this question part of your assignment? We can help"

ORDER NOW